ATLASAtara Biotherapeutics (ATRA) earnings date: Nov 11, 2026
Atara Biotherapeutics (ATRA) reports earnings for the quarter ended Sep 30, 2026 on Wed, Nov 11, 2026.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on ATRA
| Last price | $8.26 (+3.1%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.3% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Atara Biotherapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Atara Biotherapeutics reports on Nov 11, 2026. One email the day before, with ATLAS’s read on Atara Biotherapeutics. You can switch it off at any time.
Alert me before ATRA reportsFree to start. Creating an account takes under a minute.
Notify me when Atara Biotherapeutics reports
Track ATRA free Add Atara Biotherapeutics to a free ATLAS watchlist and see its next report date in one place.
ATRA earnings at a glance
| Next report (confirmed) | Wed, Nov 11, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| Last report | Aug 12, 2026 · Miss |
| Beat rate (last 5 reports) | 3 of 5 (60%) |
| Average EPS surprise | -29.9% |
| Average move around a report | ±8.1% (last 5) |
| Sector | Healthcare · Biotechnology |
Atara Biotherapeutics earnings history: last 5 reports
Atara Biotherapeutics last reported on Aug 12, 2026: EPS of -$0.32 against an estimate of -$0.25 (-28.0% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 12, 2026 | -$0.25 | -$0.32 | -28.0% | Miss | -4.8% |
| Jul 30, 2026 | $2.51 | $2.62 | +4.4% | Beat | +4.0% |
| Jun 11, 2026 | -$0.33 | -$0.09 | +72.7% | Beat | +5.6% |
| Mar 16, 2026 | -$0.10 | -$0.35 | -250.0% | Miss | -19.5% |
| Nov 12, 2025 | -$0.66 | -$0.32 | +51.5% | Beat | +6.6% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for ATRA
See the fair value, the probability range and the earnings history of Atara Biotherapeutics on its ATLAS page.
Atara Biotherapeutics (ATRA) stock analysisPlans from €3.99 a month.
Atara Biotherapeutics earnings: frequently asked questions
When does Atara Biotherapeutics (ATRA) report earnings?
Atara Biotherapeutics is scheduled to report on Wednesday, November 11, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
How often does ATRA beat earnings estimates?
Of its last 5 reports with a recorded result, Atara Biotherapeutics beat the EPS estimate 3 times; the average surprise was -29.9%. Past results do not predict the next one.
How much does ATRA move around earnings?
Over its last 5 reports the stock moved an average of 8.1% (absolute, from the close before the report day to the close after it), and finished higher 3 of 5 times.
Did Atara Biotherapeutics beat earnings estimates last quarter?
Atara Biotherapeutics last reported on Aug 12, 2026: EPS of -$0.32 against an estimate of -$0.25 (-28.0% surprise), a miss.
How much does ATRA usually move in a day?
On a normal trading day the ATLAS model puts ATRA’s one-day range at about ±4.3%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 11, 2026
Educational information, not investment advice. Disclaimer